COR Stock Overview
Cencora, Inc. sources and distributes pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Cencora, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$249.69 |
| 52 Week High | US$251.56 |
| 52 Week Low | US$195.83 |
| Beta | 0.44 |
| 11 Month Change | 6.90% |
| 3 Month Change | 5.09% |
| 1 Year Change | 25.15% |
| 33 Year Change | 118.87% |
| 5 Year Change | 182.58% |
| Change since IPO | 8,355.11% |
Recent News & Updates
Recent updates
Cencora (NYSE:COR) Is Increasing Its Dividend To $0.55
Nov 09
Why We're Not Concerned About Cencora, Inc.'s (NYSE:COR) Share Price
Oct 31Here's Why We Think Cencora (NYSE:COR) Is Well Worth Watching
Oct 10Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Sep 18Cencora: Credentials To Die For, But Underlying Issues Make Case For 'Hold' Rating
Sep 18Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings
Jul 16Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning
Jun 30Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?
Jun 28Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly
Jun 09Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?
May 21Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings
Apr 05Cencora Remains Chronically Undervalued, With Material Growth Potential
Mar 25Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price
Mar 18Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly
Feb 25Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Feb 07Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price
Jan 05Cencora: Continued Economic Value On The Table Across All Investment Horizons
Jan 04A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)
Dec 15Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year
Nov 05Is Cencora (NYSE:COR) A Risky Investment?
Nov 03Cencora: New Name, Same Old Economic Leverage, Reiterate Buy
Oct 18AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate
Aug 01AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)
Jul 28We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt
Jun 19Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?
May 01Shareholder Returns
| COR | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 2.7% | 4.1% | 2.0% |
| 1Y | 25.1% | 4.6% | 32.4% |
Return vs Industry: COR exceeded the US Healthcare industry which returned 4.6% over the past year.
Return vs Market: COR underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| COR volatility | |
|---|---|
| COR Average Weekly Movement | 2.9% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: COR has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: COR's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1871 | 44,000 | Bob Mauch | www.cencora.com |
Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Cencora, Inc. Fundamentals Summary
| COR fundamental statistics | |
|---|---|
| Market cap | US$48.02b |
| Earnings (TTM) | US$1.51b |
| Revenue (TTM) | US$293.96b |
32.0x
P/E Ratio0.2x
P/S RatioIs COR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| COR income statement (TTM) | |
|---|---|
| Revenue | US$293.96b |
| Cost of Revenue | US$284.17b |
| Gross Profit | US$9.79b |
| Other Expenses | US$8.28b |
| Earnings | US$1.51b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.81 |
| Gross Margin | 3.33% |
| Net Profit Margin | 0.51% |
| Debt/Equity Ratio | 557.8% |
How did COR perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield27%
Payout RatioDoes COR pay a reliable dividends?
See COR dividend history and benchmarks| Cencora dividend dates | |
|---|---|
| Ex Dividend Date | Nov 15 2024 |
| Dividend Pay Date | Nov 29 2024 |
| Days until Ex dividend | 13 days |
| Days until Dividend pay date | 1 day |
Does COR pay a reliable dividends?
See COR dividend history and benchmarks